Dolinnov
PrivateLast Round
Seed
Oct 1, 2024
Total Funding Raised
$1.73M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Dolinnov is a biotechnology company developing precision RNA therapeutics for chronic pain, specifically targeting the FXYD2 protein to provide non-opioid pain relief.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dolinnov Comparables
Compare Dolinnov with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quiver Bioscience | 78% | |
| Latigo Biotherapeutics | 71% | |
| Exicure, Inc. | 69% | |
Dolinnov Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 1, 2024 |
Dolinnov Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bpifrance | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
Grew 100% QoQ from 4 to 8 employees.
- Mar 1, 2026
Monthly visitors increased 470% MoM.
Dolinnov Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dolinnov's valuation, stock price, and market status.